PT Aurogen Pharma Indonesia represents a significant milestone as a subsidiary of Aurobindo Pharma Limited, entering Indonesia's dynamic pharmaceutical landscape in 2023.

Established in 1986 in Hyderabad, Aurobindo Pharma Ltd. has built an impressive reputation in the global pharmaceutical industry with an ambitious vision to achieve recognition among the world's top 25 pharmaceutical companies by 2030. Its mission centers on becoming a globally trusted pharmaceutical partner through continuous innovation, research excellence, and the development of high-quality pharmaceutical solutions.

Aurobindo Pharma Ltd. demonstrates its commitment to global healthcare by developing, manufacturing, and distributing an extensive portfolio of pharmaceutical products including generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectable medications - all manufactured to meet only the most stringent international regulatory standards. With a robust global presence spanning over 150 countries, Aurobindo continues to strengthen its position as a reliable partner in the worldwide pharmaceutical community.